Melbourne, Vic., Australia.
Brisbane, Qld, Australia.
Aliment Pharmacol Ther. 2019 Apr;49(8):1040-1051. doi: 10.1111/apt.15209. Epub 2019 Mar 7.
Decision support tools may facilitate shared decision-making and improve quality of care.
To assess the effectiveness of a decision support tool on improving quality of care in ulcerative colitis.
A prospective quality of care intervention was conducted at two Australian hospitals comparing out-patient-based ulcerative colitis care with, and without, a tablet-based decision support tool. This included questions on disease activity management; psychological well-being; and preventive care, with 13 process indicators relevant to each domain. Participants included adult out-patients with mild-to-moderate ulcerative colitis and their clinicians who were divided into two cohorts. The first cohort were followed up immediately after their clinical review to check whether their clinician had discussed the 13 process indicators during the consultation. The second cohort of patients used the decision support tool immediately prior to their consultation which then generated a suggested management plan for the patient and clinician to discuss during the consultation. Management between the 2 cohorts was compared to assess the effectiveness of the decision support tool in improving the primary outcome, defined as the proportion of quality process indicators used for ulcerative colitis care, with and without the decision support tool.
Thirteen physicians and 100 patients participated. Fifty patients were managed without the decision support tool using standard care (median age 40; 44% male), and 50 patients used the decision support tool (median age 40; 46% male) over a 20-week period. Increase in the median use of process indicators overall was observed following use of the decision support tool (27% vs 100%; P < 0.001). Improvements were seen in psychological well-being management (30% vs 100%; P < 0.001), preventive care (16% vs 100%; P < 0.001) and process indicators related to disease activity management (50% vs 100%; P < 0.001). The decision support tool was found to be usable and acceptable. Shared decision-making was greater in the post-intervention group (mean decision conflict score of 18.0 vs 33.5; P = 0.002).
The decision support tool substantially improved the quality of the delivery of care. Decision support tools have the potential to minimise errors of omission via a standardised approach to care.
决策支持工具可以促进共同决策并提高医疗质量。
评估决策支持工具在溃疡性结肠炎患者中的应用效果,以改善医疗质量。
在澳大利亚的两家医院进行了一项前瞻性医疗质量干预研究,比较了基于门诊的溃疡性结肠炎护理与使用平板电脑决策支持工具的护理,其中包括疾病活动管理、心理健康和预防保健相关的问题,每个领域都有 13 个过程指标。参与者包括轻度至中度溃疡性结肠炎的成年门诊患者及其临床医生,他们被分为两组。第一组患者在临床评估后立即进行随访,以检查其临床医生在咨询过程中是否讨论了 13 个过程指标。第二组患者在就诊前立即使用决策支持工具,然后生成一份针对患者和临床医生的管理计划,供他们在咨询过程中讨论。比较两组之间的管理情况,以评估决策支持工具在改善主要结局方面的有效性,该结局定义为使用决策支持工具和不使用决策支持工具进行溃疡性结肠炎护理的质量过程指标的比例。
共有 13 名医生和 100 名患者参与了研究。50 名患者在没有决策支持工具的情况下接受标准护理(中位数年龄为 40 岁,44%为男性),50 名患者在 20 周内使用了决策支持工具(中位数年龄为 40 岁,46%为男性)。使用决策支持工具后,过程指标的中位数使用量总体上有所增加(27% vs 100%;P<0.001)。在心理健康管理(30% vs 100%;P<0.001)、预防保健(16% vs 100%;P<0.001)和疾病活动管理相关过程指标(50% vs 100%;P<0.001)方面均有改善。该决策支持工具被证明是可用且可接受的。干预后组的共同决策明显更多(决策冲突评分均值为 18.0 分 vs 33.5 分;P=0.002)。
决策支持工具显著提高了医疗服务的质量。决策支持工具通过标准化的护理方法有潜力减少遗漏错误。